
Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
In May 2025, a Research Memo featuring research conducted by LDI Executive Director Rachel M. Werner, MD, PhD and LDI Senior Fellows Eric T. Roberts, PhD, Atheendar Venkataramani, MD, PhD, Paula Chatterjee, MD, MPH, Norma Coe, PhD, Molly Candon, PhD, Emily F. Gregory, MD, MHS, Margaret Lowenstein, MD, MPhil, MSHP, and Aditi Vasan, MD, MSHP was presented to staff of the U.S. Senate Committee on Finance.
The memo contained research on various aspects of Medicaid such as work requirements, the long-term care workforce, pregnancy care, and coverage for children.
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Comment: Delivered to the Senate Committee on Health, Education, Labor, and Pensions
Research Memo: Response to Request for Technical Assistance
Research Memo: Supplement to Response to Request for Technical Assistance